Plus Therapeutics Inc (NASDAQ: PSTV) started the day on Wednesday, with a price decrease of -7.39% at $0.54, before settling in for the price of $0.58 at the close. Taking a more long-term approach, PSTV posted a 52-week range of $0.16-$2.31.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 46.51%. Meanwhile, its Annual Earning per share during the time was 46.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 90.77%. This publicly-traded company’s shares outstanding now amounts to $92.18 million, simultaneously with a float of $91.55 million. The organization now has a market capitalization sitting at $53.75 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5624, while the 200-day Moving Average is $0.6830.
Plus Therapeutics Inc (PSTV) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Plus Therapeutics Inc’s current insider ownership accounts for 7.77%, in contrast to 3.21% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’25, this organization’s Director bought 110,000 shares at the rate of 0.49, making the entire transaction reach 53,779 in total value, affecting insider ownership by 139,327.
Plus Therapeutics Inc (PSTV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
Plus Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 90.77% and is forecasted to reach -0.12 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 62.44% through the next 5 years, which can be compared against the 46.51% growth it accomplished over the previous five years trading on the market.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
Let’s observe the current performance indicators for Plus Therapeutics Inc (PSTV). It’s Quick Ratio in the last reported quarter now stands at 1.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.10.
In the same vein, PSTV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.23, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be -0.12 at the market close of one year from today.
Technical Analysis of Plus Therapeutics Inc (PSTV)
If we take a close look at the recent performances of Plus Therapeutics Inc (NASDAQ: PSTV), its last 5-days Average volume was 7.37 million that shows plunge from its year to date volume of 20.36 million. During the previous 9 days, stock’s Stochastic %D was recorded 13.22% While, its Average True Range was 36.55.
Raw Stochastic average of Plus Therapeutics Inc (PSTV) in the period of the previous 100 days is set at 48.88%, which indicates a major rise in contrast to 0.78% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0597 that was lower than 0.0669 volatility it exhibited in the past 100-days period.
